Business Standard
Thursday, May 31, 2012
drived banner
drived banner
  Advanced Search
RSS
Content Guide
Follow us on  
||||||||Technology| 
 Section Home | News Now | Features & Analysis | IT/ITES | Telecom | Hardware | Columnists | Gadgets & Gizmos
Home > Tech World Live Markets | Commodities
 

Raju needs continuous treatment for six weeks: NIMS
BS Reporter / Chennai/ Hyderabad Mar 12, 2010, 00:04 IST

Satyam Computer Services Limited founder B Ramalinga Raju needs continuous treatment as in-patient for four to six more weeks as he carries a very high risk for morbidity, according to Nizam's Institute of Medical Sciences (NIMS) professor and head of gastroenterology department Dr Ajit Kumar.

Raju, the prime accused in Satyam scam, is suffering from Hepatitis C and is being treated at NIMS. Citing his treatment, he did not appear before the special court when summoned. Following this, the court asked NIMS to submit a status report on Raju's health condition.

BSE | NSE
Price  
Mahindra Satyam
Though NIMS submitted a report last week, the court categorically asked the hospital if Raju was in a position to attend the court in person. Following this, NIMS again submitted a report saying Raju needed continuous treatment.

The NIMS doctors initially said Raju required 6-8 weeks' treatment but it is now over four months since he is in the hospital, the Central Bureau of Investigation, probing the case, pointed out. Special judge BVLN Chakravarti posted the matter for March 18.

Meanwhile, the court also extended the judicial remand of all the 10 accused till March 18.

New Ipad Application :Business Standard's all new IPad App
Click here to download for free
Arrow Other Stories     
- Markets end lower ahead of May F&O expiry
- Parsvnath posts Rs 23 cr loss in Q4
- Educomp net down 57% at Rs 61 cr in Jan-Mar qtr
- DLF Q4 net plunges 39% to Rs 211 cr
- Provogue Q4 net profit down 71% at Rs 1.81 cr
  Read Business news in 
- India's no. 1 Property Site. Click here to know more
- Help a Child Achieve her. Click to know more
- Watch The Film Here. Click here to know more..
- 1 billion in saving for Unilever without any tangles.
- One Partnership Endless Possibilities. Click here to know more
- Helping doctors detect diseases earlier, saving costs & extending lives.
- Which is the best plan for your daughter
- Check out the TRUE COLOURS of your Stocks, Now for FREE!
- 2 Lac Apartments, 1 Lac House / Plots. Click here
Sorry, comments to this story are closed
Latest Messages
Table for Two
  Now available at Special price
  Rs.280/- Only

  Buy Now
BS POLL
UPA 2 has completed three years. How do you rate its performance?  Read the story
  Good
  Average
  Bad
Submit
Most Popular
Read
E-Mailed
Commented
   
- Vodafone notice on arbitration premature: Govt
- Coal blocks for infrastructure projects get GoM nod
- Tata Motors skids as margins dip at JLR
- Dissidence brewing in state: Senior BJP leaders team up against Modi
- Rupee-sensitive stocks risky for new investors
 
 More  
New Ipad Application
 Business Standard's all new IPad  App
 Click here to download for free
  Hot Searches  
 
Apalya |  Air India |  GAAR |  Agni  |  Solar eclipse |  Satyamev Jayate |  SRK |  Aamir Khan |  IPL |  Ertiga |  Sarfaesi Act |  Vodafone |  JP Morgan |  Transfer pricing |  Rupee |  Kingfisher Airlines |  Silver |  Provident Fund |  income tax refund |  iPhone |  Reliance Industries |  SEBI |  BSNL |  BSE |  NSE |  Mukesh Ambani |  Anil Ambani |  Infosys |  Pranab Mukherjee |  Sonia Gandhi |  Rahul Gandhi |  New Pension Scheme |  Reliance |  RBI |  GDP |  Gold |  Ratan Tata |  ICICI |  B-School |  Sensex |  Tax calculator |  Home Loan |  Personal Finance |  inflation |  oil prices |  Barack Obama |   
 
  Member Area Write to the Editor RSS Archives Advanced Search
  Subscribe to BS print product BS e-paper Newsletter Portfolio Tracker
  BS Products BS Hindi BS Motoring BS Books
Home | Markets & Investing | Companies & Industry | Banking & Finance | Economy & Policy | Opinion
Life & Leisure | Management & Marketing | Tech World | General News
About Us | Partner With Us | Code of Conduct | Careers | Advertise with us| Terms & Conditions | Disclaimer | Contact Us